Most Read Articles
22 Nov 2020
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

4 days ago
Vitamin D deficiency may be a contributing factor to the mortality rate among patients with the novel coronavirus disease (COVID-19), reports a new study.
Pearl Toh, 2 days ago
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.

Free fatty acid C22:6 predicts type 2 diabetes mellitus

01 Nov 2020

Serum levels of the free fatty acid (FFA) C22:6 appear to be a strong indicator of an individual’s susceptibility to type 2 diabetes mellitus (T2DM), a new study has found.

Researchers enrolled 40 participants aged 30–60 years who were divided into three groups: normal weight (NW; n=20), obese (OB; n=10), and T2DM (n=10). Ultra-high-pressure liquid chromatography-mass spectrometry (UHPLC-MS) was used to quantify FFAs in serum samples.

Using an orthogonal partial least squares determinant analysis (OPLS-DA) model, the researchers saw that NW and OB participants showed substantial metabolic difference in terms of their FFA profiles. Specifically, 14 FFAs explained this discrepancy, including FFA C8;10, C10:0, C20:20, C22:6, and C13:0. All differentially measured FFAs were enriched in the OB vs NW group.

Against the T2DM group, NW participants also saw significantly different levels of nine FFAs (including C14:0, C20:1, C20:3, C18:3, and C22:6), all of which were present in higher levels in T2DM participants.

Taken together, the levels of a total of six FFAs were elevated in both the OB and T2DM participants, and were highest in the latter subgroup. These FFAs were: C14:0, C18:1, C20:2, C20:3, C20:5, and C22:6. All six of these FFAs shared a positive and significant interaction with fasting plasma glucose concentrations, as well as with a number of other metabolic indicators, such as body mass index and triglyceride levels.

Receiver operating characteristic curve analysis found that C22:6 and C18:1 had the highest predictive potential of the six FFAs identified, with areas under the curve of 0.803 and 0.743, respectively. These were followed by C14:0 and C20:3, with corresponding values of 0.727 and 0.720. The remaining two were underpowered for T2DM prediction.

Binary logistic regression analysis finally found that only C22:6 remained significantly and positively indicative of the risk of T2DM after controlling for confounders (β, 1.311, 95 percent confidence intervals, 1.328–10.371).

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
22 Nov 2020
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

4 days ago
Vitamin D deficiency may be a contributing factor to the mortality rate among patients with the novel coronavirus disease (COVID-19), reports a new study.
Pearl Toh, 2 days ago
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.